GW Pharmaceuticals PLC

GWPH-Q

NASDAQ:GWPH

97.14
2.36 (2.37%)
GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols. Sativex is the first natural cannabis plant derivative to gain market approval in any country.
More at Wikipedia

Analysis and Opinions about GWPH-Q

Signal
Opinion
Expert
BUY
BUY
September 14, 2020
A biopharma that makes cannabis. It carried an unfair negative assocIation (to some investors). They make a drug, Epidiolex, that treats children with a form of epilepsy. It's undervalued.
Show full opinionHide full opinion
A biopharma that makes cannabis. It carried an unfair negative assocIation (to some investors). They make a drug, Epidiolex, that treats children with a form of epilepsy. It's undervalued.
PAST TOP PICK
PAST TOP PICK
June 5, 2017

(Top Pick Jun 1/16, Up 7%) He bought and sold it a few different times in the last year. They make several drugs. They have several trials with positive news having come out in the last year. One or two new drugs will get approved in the next year. He still likes it, but keep in mind the aggressiveness that comes with it.

Show full opinionHide full opinion

(Top Pick Jun 1/16, Up 7%) He bought and sold it a few different times in the last year. They make several drugs. They have several trials with positive news having come out in the last year. One or two new drugs will get approved in the next year. He still likes it, but keep in mind the aggressiveness that comes with it.

TOP PICK
TOP PICK
June 1, 2016

A UK company. They use synthetic cannabinoids to create drugs that are used to fight seizures and pain. This has been lumped into the cannabis/marijuana sector. Had their phase 3 updated results for a drug for seizures in children under 1 year of age. In the next month, there are 2 phase 3 trials that are coming in from the FDA, and he believes that 1, possibly 2 are going to be approved.

Show full opinionHide full opinion

A UK company. They use synthetic cannabinoids to create drugs that are used to fight seizures and pain. This has been lumped into the cannabis/marijuana sector. Had their phase 3 updated results for a drug for seizures in children under 1 year of age. In the next month, there are 2 phase 3 trials that are coming in from the FDA, and he believes that 1, possibly 2 are going to be approved.

Showing 1 to 3 of 3 entries
  • «
  • 1
  • »

GW Pharmaceuticals PLC(GWPH-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for GW Pharmaceuticals PLC is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

GW Pharmaceuticals PLC(GWPH-Q) Frequently Asked Questions

What is GW Pharmaceuticals PLC stock symbol?

GW Pharmaceuticals PLC is a American stock, trading under the symbol GWPH-Q on the NASDAQ (GWPH). It is usually referred to as NASDAQ:GWPH or GWPH-Q

Is GW Pharmaceuticals PLC a buy or a sell?

In the last year, 1 stock analyst published opinions about GWPH-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for GW Pharmaceuticals PLC.

Is GW Pharmaceuticals PLC a good investment or a top pick?

GW Pharmaceuticals PLC was recommended as a Top Pick by Jim Cramer - Mad Money on 2020-09-14. Read the latest stock experts ratings for GW Pharmaceuticals PLC.

Why is GW Pharmaceuticals PLC stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is GW Pharmaceuticals PLC worth watching?

1 stock analyst on Stockchase covered GW Pharmaceuticals PLC In the last year. It is a trending stock that is worth watching.

What is GW Pharmaceuticals PLC stock price?

On 2020-09-29, GW Pharmaceuticals PLC (GWPH-Q) stock closed at a price of $97.14.